Evo - Elekta

Radiation Therapy Machines

Information

Elekta Evo is the only CT-Linac offering unparalleled versatility for treating a full spectrum of cancer patients. Elekta Evo introduces new state-of-the-art imaging that unlocks a comprehensive suite of online and offline adaptive capabilities. This enables you to treat a diverse range of clinical indications from electrons to Stereotactic Radiosurgery (SRS) with precision that’s built into the design. Its versatility empowers your department to select from a wide range of external beam radiotherapy techniques and adopt new treatments at a pace that suits both your clinic and clinical workflows. With Elekta Evo, you can go further than ever before, starting with Iris, high definition, AI-enhanced imaging. Iris further enhances IGRT and unlocks online and offline adaptive treatments, providing highly personalized care for every patient in every treatment session. When purchasing Elekta Evo, we are in it together to support you in adopting new radiotherapy techniques. Elekta Evo is powered by Elekta ONE, giving you up-to-date access to our latest innovations. Elekta stands by your side to support you on your adaptive journey and connects you to a wealth of knowledge through a community of peers. Elekta Evo. Adapt at your rhythm.

Elekta LtdS1.G10For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer and brain disorders has access to – and benefits from – more precise, personalized radiotherapy treatments. Elekta’s inherent, innovative strength fuels the development of precision radiation medicine. This comprises two elements: the opportunity to target radiation therapy with precision in a way that was previously impossible; and the ability to leverage the potential of enormous data volumes using intelligent automation, which improves the treatment processes, the ease of use, and the quality of life for patients. We work actively to achieve a good balance between offering cost-effective care to as many people as possible, and the development of cutting-edge solutions for treating the most complicated forms of cancer. This past year, Elekta reached pivotal milestones, shifting the treatment paradigm of radiation oncology for clinicians and patients across the globe. One example is Elekta Unity, a cutting-edge magnetic resonance radiation therapy (MR/RT) technology. Unity enables high-field MR images while radiation is being delivered, allowing clinicians to adapt treatment based on the patient’s daily anatomy. The ability to scan, plan and treat in real time has been the long-sought vision of radiation oncologists. Elekta will continue to attentively assess its technologies, advancing new solutions to make cancer a more manageable disease. Our commitment is built on a combination of curiosity, innovation and proximity to our customers. We are proud to be the leading innovator in precision radiation medicine. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.